ImmunityBio Inc (STU:26CA)
€ 6.044 0.014 (0.23%) Market Cap: 4.10 Bil Enterprise Value: 4.62 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Immunitybio Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 02:00PM GMT
Release Date Price: €2.82 (+6.02%)
Kelly Shi
(Trades, Portfolio) LLC - Analyst

Good morning, everyone. Thank you for attending Jefferies New York Healthcare Conference. And my name is Kelly Shi, one of the biotech analysts here.

And we are very pleased to have Dr. Patrick Soon-Shiong, Executive Chairman and the Global Chief Scientific and Medical Officer. Patrick will start with storytelling of ImmunityBio and what they are working on and we'll start from here. And welcome, Patrick.

Patrick Soon;Shiong
ImmunityBio, Inc. - Chairman

Thank you, Kelly.

Okay. Well, I don't have any slides today, so what we can to be doing is we'll have a Q&A session. This is a forward-looking statement.

And I think as you all know, we're deep into bladder cancer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot